Toward Whole-Transcriptome Editing with CRISPR-Cas9

Slides:



Advertisements
Similar presentations
Structure of a Ubiquitin E1-E2 Complex: Insights to E1-E2 Thioester Transfer Shaun K. Olsen, Christopher D. Lima Molecular Cell Volume 49, Issue 5, Pages.
Advertisements

Cost of Unneeded Proteins in E. coli Is Reduced after Several Generations in Exponential Growth Irit Shachrai, Alon Zaslaver, Uri Alon, Erez Dekel Molecular.
The Mitochondrial Basis of Aging Nuo Sun, Richard J. Youle, Toren Finkel Molecular Cell Volume 61, Issue 5, Pages (March 2016) DOI: /j.molcel
How Cholesterol-Dependent Cytolysins Bite Holes into Membranes
A CRISPR View of Cleavage
Volume 58, Issue 5, Pages (June 2015)
Expanding the Biologist’s Toolkit with CRISPR-Cas9
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Central Dogma Goes Digital
Grounded: Transcriptional Pausing in Naive mESCs
Nat. Rev. Rheumatol. doi: /nrrheum
HSF1 in Translation Cancer Cell
HuD Stimulates Translation via eIF4A
Structural Insights into Riboswitch Control of the Biosynthesis of Queuosine, a Modified Nucleotide Found in the Anticodon of tRNA  Mijeong Kang, Robert.
Regulation of rRNA Processing: A Role for a Unique GTPase
Methed-Up FOXOs Can't In-Akt-ivate
Skill Development in Graduate Education
Wenlian Qiao, Peter W. Zandstra  Cell Stem Cell 
A Pause to Splice Molecular Cell
DNA Polymerases at the Replication Fork in Eukaryotes
PU.1 Takes Control of the Dendritic Cell Lineage
Coordinate Transcriptional Regulation by ERG and Androgen Receptor in Fusion- Positive Prostate Cancers  Yu Chen, Charles L. Sawyers  Cancer Cell  Volume.
How To Choose a Good Scientific Problem
A New Link in the Chain from Amino Acids to mTORC1 Activation
Volume 54, Issue 4, Pages (May 2014)
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Volume 46, Issue 5, Pages (June 2012)
Volume 62, Issue 1, Pages (April 2016)
Karin Johanna Ferrari, Elisa Lavarone, Diego Pasini  Molecular Cell 
From Protein-RNA Predictions toward a Peptide-RNA Code
Take Your PICS: Moving from GWAS to Immune Function
RNA: Jack of All Trades and Master of All
Correlation Does Not Imply Causation: Histone Methyltransferases, but Not Histone Methylation, SET the Stage for Enhancer Activation  Tim Pollex, Eileen.
Joseph W. Briggs, Jonathan D. Dinman  Molecular Cell 
William G. Kaelin, Peter J. Ratcliffe  Molecular Cell 
Eukaryotic Transcription Activation: Right on Target
Trans-Splicing to Spliceosomal U2 snRNA Suggests Disruption of Branch Site-U2 Pairing during Pre-mRNA Splicing  Duncan J. Smith, Charles C. Query, Maria.
Rewriting the Epigenome
Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR
Joseph W. Briggs, Jonathan D. Dinman  Molecular Cell 
Lucas T. Gray, Alan M. Weiner  Molecular Cell 
David N. Criddle, Alexei V. Tepikin  Molecular Cell 
Global Patterns of Methylation in Sézary Syndrome Provide Insight into the Role of Epigenetics in Cutaneous T-Cell Lymphoma  Sean Whittaker  Journal of.
Small Molecules, Big Effects: A Role for Chromatin-Localized Metabolite Biosynthesis in Gene Regulation  Bryan A. Gibson, W. Lee Kraus  Molecular Cell 
Barbara Jusiak, Sara Cleto, Pablo Perez-Piñera, Timothy K. Lu 
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
New Insights into Genome Structure: Genes of a Feather Stick Together
Nuclear Decay Factors Crack Up mRNA
Structural Insights into Riboswitch Control of the Biosynthesis of Queuosine, a Modified Nucleotide Found in the Anticodon of tRNA  Mijeong Kang, Robert.
Easy Stress Relief by EZH2
CRISPR-Mediated Base Editing without DNA Double-Strand Breaks
Volume 32, Issue 6, Pages (December 2008)
Volume 49, Issue 1, Pages 1-3 (January 2013)
521. Multiplex Genome Editing of TCR°/CD52 Genes as a Platform for “Off the Shelf” Adoptive T-Cell Immunotherapies    Molecular Therapy  Volume 22, Pages.
Amino Acid Signaling to TOR Activation: Vam6 Functioning as a Gtr1 GEF
Volume 66, Issue 4, Pages e4 (May 2017)
m6A mRNA Methylation: A New Circadian Pacesetter
Structure of an RNA Silencing Complex of the CRISPR-Cas Immune System
Functional Enhancer Screening in Single Cells
Alessandro Bonetti, Piero Carninci  Molecular Cell 
Molecular Mechanisms of Long Noncoding RNAs
Molecular Therapy  Volume 18, Pages S260-S261 (May 2010) DOI: /S (16)
Barrier Function at HMR
Silencing the Transcriptome's Dark Matter: Mechanisms for Suppressing Translation of Intergenic Transcripts  Kellie S. Bickel, David R. Morris  Molecular.
Antonino Montalbano, Matthew C. Canver, Neville E. Sanjana 
How To Choose a Good Scientific Problem
Volume 61, Issue 2, Pages (January 2016)
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor α-Bound Enhancers  Julia B. Carleton, Kristofer.
Volume 25, Issue 2, Pages (January 2007)
RNA Processing: Redrawing the Map of Charted Territory
Presentation transcript:

Toward Whole-Transcriptome Editing with CRISPR-Cas9 Dirk Heckl, Emmanuelle Charpentier  Molecular Cell  Volume 58, Issue 4, Pages 560-562 (May 2015) DOI: 10.1016/j.molcel.2015.05.016 Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 1 Second-Generation CRISPRa Systems (A–C) Schematic representation of first-generation and second-generation CRISPRa systems. First-generation CRISPRa with dCas9-VP64 (4× VP16) fusion is shown in (A). Second-generation SunTag-dCas9 with 10× antibody epitope fusion bound by scFv-sfGFP(GFP)-VP64 fusion proteins is shown in (B). Reported window of activity relative to the TSS is indicated (−50 to −400 nucleotides from TSS). In (C), a second-generation dCas9-VP64 fusion with MS2-aptamer modified sgRNA bound by MCP-p65-HSF1 fusion proteins is shown. Reported window of activity relative to the TSS is indicated (−1 to −200 nucleotides from TSS). (D) Approximate reported activation of the second-generation systems compared to first generation. Activation was measured at different loci with different sgRNAs excluding direct comparison of the SunTag- and MS2-based systems. (E) Reported sgRNA libraries and applicability of the SunTag- and MS2-based systems. (F) Inverse correlation of binding distance to TSS and transcriptional activation reported by Konermann et al. (G) Correlation of basal gene transcription and transcriptional activation reported by Konermann et al. (H) Potential multiplexing of different RNA-aptamer/aptamer-binding proteins as proposed by Zalatan et al. transferred to the sgRNA2.0 design by Konermann et al. Conceivable use of activators, repressors, or epigenetic modifiers at different loci is represented. (I) Potential multiplexing of orthogonal Cas9 proteins and different scFv/scFv-epitope combinations as in (H). Molecular Cell 2015 58, 560-562DOI: (10.1016/j.molcel.2015.05.016) Copyright © 2015 Elsevier Inc. Terms and Conditions